{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:44:29Z","timestamp":1793166269692,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.autrev.2023.103415","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T11:34:57Z","timestamp":1692790497000},"page":"103415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases?"],"prefix":"10.1016","volume":"23","author":[{"given":"Carlo","family":"Salvarani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Padoan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Iorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Tomelleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Terrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Muratore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaskar","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2023.103415_bb0005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.semarthrit.2003.09.007","article-title":"Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions","volume":"33","author":"Gonzalez-Gay","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103415_bb0010","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1001\/jama.2016.5444","article-title":"Polymyalgia rheumatica and giant cell arteritis a systematic review","volume":"315","author":"Buttgereit","year":"2016","journal-title":"JAMA - J Am Med Assoc"},{"key":"10.1016\/j.autrev.2023.103415_bb0015","first-page":"506","article-title":"The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease","volume":"56","author":"Dejaco","year":"2017","journal-title":"Rheumatol (United Kingdom)"},{"key":"10.1016\/j.autrev.2023.103415_bb0020","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(64)92784-9","article-title":"Arteritis in \u2018polymyalgia rheumatica\u2019","volume":"1","author":"Hamrin","year":"1964","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.autrev.2023.103415_bb0025","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.semarthrit.2015.06.009","article-title":"Prevalence of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica","volume":"45","author":"Narv\u00e1ez","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103415_bb0030","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.semarthrit.2018.05.007","article-title":"Predictors of positive 18F-FDG PET\/CT-scan for large vessel vasculitis in patients with persistent polymyalgia rheumatica","volume":"48","author":"Prieto-Pe\u00f1a","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103415_bb0035","first-page":"4","article-title":"Imaging in diagnosis, outcome prediction and monitoring of large vessel vasculitis: a systematic literature review and meta-analysis informing the EULAR recommendations","author":"Duftner","year":"2018","journal-title":"RMD Open"},{"key":"10.1016\/j.autrev.2023.103415_bb0040","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/art.24459","article-title":"Epidemiology of giant cell arteritis and polymyalgia rheumatica","volume":"61","author":"Gonzalez-Gay","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103415_bb0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/BOR.0b013e32833ee946","article-title":"IFN-\u03b3 and IL-17: the two faces of T-cell pathology in giant cell arteritis","volume":"23","author":"Weyand","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2023.103415_bb0050","doi-asserted-by":"crossref","first-page":"192","DOI":"10.7326\/0003-4819-123-3-199508010-00006","article-title":"The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern","volume":"123","author":"Salvarani","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2023.103415_bb0055","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.1780380311","article-title":"Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991","volume":"38","author":"Salvarani","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103415_bb0060","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0140-6736(08)61077-6","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"372","author":"Salvarani","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2023.103415_bb0065","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrrheum.2012.97","article-title":"Clinical features of polymyalgia rheumatica and giant cell arteritis","volume":"8","author":"Salvarani","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2023.103415_bb0070","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.semarthrit.2003.09.008","article-title":"Are polymyalgia rheumatica and giant cell arteritis the same disease?","volume":"33","author":"Cantini","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103415_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152017","article-title":"Subclinical giant cell arteritis in new onset polymyalgia rheumatica a systematic review and meta-analysis of individual patient data","volume":"55","author":"Hemmig","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103415_bb0080","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/art.24459","article-title":"Epidemiology of giant cell arteritis and polymyalgia rheumatica","volume":"61","author":"Gonzalez-Gay","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103415_bb0085","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/art.1780340313","article-title":"Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy","volume":"34","author":"Salvarani","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103415_bb0090","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/BOR.0000000000000292","article-title":"Varicella zoster virus triggers the immunopathology of giant cell arteritis","volume":"28","author":"Gilden","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2023.103415_bb0095","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.semarthrit.2017.02.005","article-title":"No detection of varicella-zoster virus in temporal arteries of patients with giant cell arteritis","volume":"47","author":"Muratore","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103415_bb0100","first-page":"1403","article-title":"Is giant cell arteritis an infectious disease?","volume":"33","author":"Duhaut","year":"2004","journal-title":"Biol Epidemiol Evidence Presse Med"},{"key":"10.1016\/j.autrev.2023.103415_bb0105","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1002\/art.10580","article-title":"Detection of parvovirus B19 DNA by polymerase chain reaction in giant cell arteritis: a case-control study","volume":"46","author":"Salvarani","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103415_bb0110","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/art.1780370411","article-title":"HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis","volume":"37","author":"Weyand","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103415_bb0115","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/sarh.2002.50025","article-title":"Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica","volume":"33","author":"Gonz\u00e1lez-Gay","year":"2003","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103415_bb0120","first-page":"2395","article-title":"HLA-DRB1, DQA1, and DQB1 alleles associated with giant cell arteritis in northern Italy","volume":"26","author":"Salvarani","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2023.103415_bb0125","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.semarthrit.2003.12.001","article-title":"HLA-DRB1 allele distribution in polymyalgia rheumatica and giant cell arteritis: influence on clinical subgroups and prognosis","volume":"34","author":"Mart\u00ednez-Taboda","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103415_bb0130","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/ard.58.5.303","article-title":"HLA-DRB1 alleles associated with polymyalgia rheumatica in northern Italy: correlation with disease severity","volume":"58","author":"Salvarani","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103415_bb0135","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/1529-0131(200008)43:8<1749::AID-ANR11>3.0.CO;2-K","article-title":"Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms","volume":"43","author":"Mattey","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103415_bb0140","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1084\/jem.20030850","article-title":"Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis","volume":"199","author":"Ma-Krupa","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2023.103415_bb0145","doi-asserted-by":"crossref","first-page":"e874","DOI":"10.1016\/S2665-9913(21)00253-8","article-title":"New insights into the pathogenesis of giant cell arteritis: are they relevant for precision medicine?","volume":"3","author":"Ciccia","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.autrev.2023.103415_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.01981","article-title":"Leukocyte dynamics reveal a persistent myeloid dominance in giant cell arteritis and polymyalgia rheumatica","volume":"10","author":"van Sleen","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103415_bb0155","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1002\/art.34647","article-title":"Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis","volume":"64","author":"Samson","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103415_bb0160","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1161\/CIRCULATIONAHA.109.872903","article-title":"Th17 and Th1 T-cell responses in giant cell arteritis","volume":"121","author":"Deng","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2023.103415_bb0165","first-page":"13","article-title":"Contribution of pathogenic T helper 1 and 17 cells to bursitis and tenosynovitis in polymyalgia rheumatica","author":"Reitsema","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103415_bb0170","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/art.1780390719","article-title":"Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica. Quantitative analysis and influence of corticosteroid treatment","volume":"39","author":"Meliconi","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103415_bb0175","first-page":"1071","article-title":"POS1435 A GM-CSF and IFN-\u03a5-driven pro-inflammatory macrophage signature in polymyalgia rheumatica","volume":"82","author":"Reitsema","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103415_bb0180","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/ard-2022-222873","article-title":"Expression of interleukin-6 in synovial tissue of patients with polymyalgia rheumatica","volume":"82","author":"Jiemy","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103415_bb0185","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1097\/PAS.0000000000000244","article-title":"Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations","volume":"38","author":"Cavazza","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.autrev.2023.103415_bb0190","first-page":"1750","article-title":"Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica","volume":"25","author":"Gonz\u00e1lez-Gay","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2023.103415_bb0195","first-page":"15","article-title":"Prevalence and characteristics of giant cell arteritis in patients with newly diagnosed polymyalgia rheumatica - a prospective cohort study","author":"Burg","year":"2023","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.autrev.2023.103415_bb0200","first-page":"kead189","article-title":"Prevalence and characteristics of subclinical giant cell arteritis in polymyalgia rheumatica","volume":"2","author":"De Miguel","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2023.103415_bb0205","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/1744666X.2022.2092098","article-title":"Comparing treatment options for large vessel vasculitis","volume":"18","author":"Macaluso","year":"2022","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2023.103415_bb0210","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/rheumatology\/35.7.702","article-title":"Letter to the editor. Low-dose corticosteroids and blindness in giant cell arteritis","volume":"35","author":"Gonzalez-Gay","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.autrev.2023.103415_bb0215","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z","article-title":"Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment","volume":"41","author":"Gonz\u00e1lez-Gay","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103415_bb0220","first-page":"275","article-title":"(18)F-FDG PET\/CT for the detection of large vessel vasculitis in patients with polymyalgia rheumatica","volume":"34","author":"Lavado-P\u00e9rez","year":"2015","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"10.1016\/j.autrev.2023.103415_bb0225","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/rheumatology\/kep303a","article-title":"BSR and BHPR guidelines for the management of polymyalgia rheumatica","volume":"49","author":"Dasgupta","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2023.103415_bb0230","doi-asserted-by":"crossref","first-page":"e886","DOI":"10.1016\/S2665-9913(21)00277-0","article-title":"Disease stratification in giant cell arteritis to reduce relapses and prevent long-term vascular damage","volume":"3","author":"Tomelleri","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.autrev.2023.103415_bb0235","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41584-023-00976-8","article-title":"Disease stratification in GCA and PMR: state of the art and future perspectives","volume":"19","author":"Tomelleri","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2023.103415_bb0240","article-title":"Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica","author":"Dejaco","year":"2023","journal-title":"Ann Rheum Dis"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223001490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223001490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T19:48:47Z","timestamp":1712519327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997223001490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1568997223001490"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103415","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases?","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103415"}}